Sex Differences in Treatment With ACE Inhibitors and Angiotensin Receptor Blockers in Patients With Type 1 Diabetes

被引：2

作者：

Mollsten, Anna ^{[1
]}

Toppe, Cecilia ^{[1
,2
]}

Eeg-Olofsson, Katarina ^{[3
]}

Lind, Torbjorn ^{[1
]}

机构：

[1] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden

[2] Ryhov Cty Hosp, Dept Internal Med, Jonkoping, Sweden

[3] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden

来源：

DIABETES CARE | 2019年 / 42卷 / 05期

基金：

瑞典研究理事会;

关键词：

ANTIHYPERTENSIVE TREATMENT;

D O I：

10.2337/dc18-2542

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E73 / E74

页数：2

共 50 条

[1] ACE inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes
Abuissa, H
O'Keefe, J
Bell, D
Jones, P
Marso, S
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 10A - 10A
[2] Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes
Winkelmayer, WC
Fischer, MA
Schneeweiss, S
Wang, PS
Levin, R
Avorn, J
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) : 1080 - 1087
[3] Initiation of ACE Inhibitors and Angiotensin Receptor Blockers in Elderly Patients Newly Treated for Type 2 Diabetes
Hamdi, Haithem
Moisan, Jocelyne
Gregoire, Jean-Pierre
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S288 - S288
[4] Use of ACE inhibitors and angiotensin receptor Blockers by elderly with type 2 diabetes in Quebec
Sirois, Caroline
Gregoire, Jean-Pierre
Moisan, Jocelyne
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S3 - S4
[5] Combining Angiotensin Receptor Blockers With ACE Inhibitors in Elderly Patients
Anand, Shuchi
Tamura, Manjula Kurella
[J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (01) : 11 - 14
[6] Ranolazine, ACE Inhibitors, and Angiotensin Receptor Blockers
Marciniak, Thomas A.
Serebruany, Victor
[J]. AMERICAN JOURNAL OF MEDICINE, 2019, 132 (12): : E844 - E845
[7] The impart of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes
Gillespie, EL
White, CM
Kardas, M
Lindberg, M
Coleman, CI
[J]. DIABETES CARE, 2005, 28 (09) : 2261 - 2266
[8] Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers
Kriz, W
[J]. KIDNEY INTERNATIONAL, 2004, 65 (01) : 333 - 334
[9] Can ACE Inhibitors and Angiotensin Receptor Blockers Be Detrimental in CKD Patients?
Onuigbo, Macaulay A. C.
[J]. NEPHRON CLINICAL PRACTICE, 2011, 118 (04): : C407 - C419
[10] Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus
Kawada, Tomoyuki
[J]. CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 4 - 4

← 1 2 3 4 5 →